Home Biosimilar Antibodies Immunology & Inflammation CD markers Vadastuximab (Anti-Siglec-3 / CD33) For research use only.
Not for use in humans.

Vadastuximab (Anti-Siglec-3 / CD33)

Synonyms: Anti-Human CD33 Recombinant Antibody

Vadastuximab (Anti-Siglec-3 / CD33) is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine. MW : 150 KD.

Vadastuximab (Anti-Siglec-3 / CD33)

Purity & Quality Control

Batch: A235701 Purity: 99% Protein concentration: 3.51 mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Vadastuximab (Anti-Siglec-3 / CD33) is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine. MW : 150 KD.

Product Details

CAS No. 1436390-64-5
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vadastuximab (Anti-Siglec-3 / CD33) | Vadastuximab (Anti-Siglec-3 / CD33) supplier | purchase Vadastuximab (Anti-Siglec-3 / CD33) | Vadastuximab (Anti-Siglec-3 / CD33) cost | Vadastuximab (Anti-Siglec-3 / CD33) manufacturer | order Vadastuximab (Anti-Siglec-3 / CD33) | Vadastuximab (Anti-Siglec-3 / CD33) distributor